Published :
Tables : 150
Figures : 40
Category : Healthcare
No. of Pages : 200
Report Code : HC-1281
Microfluidics Market is estimated to value over USD 53 billion by 2027 end and record a CAGR of over 21.4% during the forecast period 2020 to 2027. The global microfluidics market growth is steered by the growing insistence for point-of-care (POC) testing, rising prevalence of persistent diseases, quicker turn-around analysis time and improvements in device portability. Point-of-care testing permits healthcare professionals to conduct the patient diagnosis in an ambulance, the physician’s office, at field, hospital or at home. Devices assisted with microfluidic technology are currently deployed for point-of–care testing owing to their requirement of small sample volumes and they use channels that are micro-fabricated for analysing samples. Devices used for POC testing are already widely used in blood, HIV, glucose and haemoglobin testing sectors. The POC testing devices of the future would possibly emphasize on cancer and antibiotics therapies. The POC testing devices that are based on the microfluidic technique have massive potential in the developed as well as developing nations, owing to the high amount of population affected by such diseases. The clinical diagnostics segment is likely to hold the largest global microfluidics market share and is predicted to exhibit a substantial growth rate over the forecast time frame. A substantial area of application for microfluidics is clinical diagnostics. Diseases, for instance, toxicity, can be identified by undertaking multiple biochemical analysis procedures and by symptom observation. The changes occurring in the blood of the patients can signify organ dysfunction or damage, before observable damages of the microscopic cells or other kinds of symptoms. There has been an increase in the insistence for the development of an inexpensive and easy-to-handle biochip for clinical diagnostics by using plastic microfluidic chips that are fully integrated and which have the identifying or sampling capability of reliable and fast metabolic parameter measurements from a patient and that too with no or minimal invasion. Therefore, the augmentation of clinical diagnostics is predicted to aid the expansion of the global microfluidics market size. The North America region accounts the largest microfluidics market share and it is predicted to continue its domination over the forecast period. This is credited to factors, for instance, the better reimbursement policies coupled with a well-established healthcare system and the higher adoption rate of advanced therapies amongst the population. Microfluidics is growing at a meteoric pace, especially in the U.S, with respect to massive budget sanctions for research and development. Point-of-care and molecular diagnostics primarily use microfluidic techniques for multiple applications, and thus, they account a large market share in the U.S. Due to this, the U.S holds most of the market share in the North American region. Major market players are Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson and Co., Illumina, F. Hoffmann-La Roche, Fluidigm Corp., Dolomite Microfludics, Qiagen, Abbott Laboratories, Biomerieux, Microfludic Chipshop, Elveflow, Celix, Micronit Microtechnologies. Microfluidics Market Segmentation: By Application In-Vitro Diagnostics Point-of-Care Testing Clinical Diagnostics Pharmaceutical and Life Science Research Lab Analytics Proteomic Analysis Genomic Analysis Cell-Based Assays Capillary Electrophoresis Microdispensing Microreaction Drug Delivery Laboratory Testing Agro Food Testing Industrial Testing Environmental Testing By Component By Type Microfluidic Chips Microfluidic Sensors Micropumps Microneedles Other Components By Material Polymer Glass Silicon Other Materials By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global microfluidics market by application, by component and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The global microfluidics market growth is steered by the growing insistence for point-of-care (POC) testing, rising prevalence of persistent diseases, quicker turn-around analysis time and improvements in device portability.
Point-of-care testing permits healthcare professionals to conduct the patient diagnosis in an ambulance, the physician’s office, at field, hospital or at home. Devices assisted with microfluidic technology are currently deployed for point-of–care testing owing to their requirement of small sample volumes and they use channels that are micro-fabricated for analysing samples. Devices used for POC testing are already widely used in blood, HIV, glucose and haemoglobin testing sectors. The POC testing devices of the future would possibly emphasize on cancer and antibiotics therapies.
The POC testing devices that are based on the microfluidic technique have massive potential in the developed as well as developing nations, owing to the high amount of population affected by such diseases.
The clinical diagnostics segment is likely to hold the largest global microfluidics market share and is predicted to exhibit a substantial growth rate over the forecast time frame.
A substantial area of application for microfluidics is clinical diagnostics. Diseases, for instance, toxicity, can be identified by undertaking multiple biochemical analysis procedures and by symptom observation. The changes occurring in the blood of the patients can signify organ dysfunction or damage, before observable damages of the microscopic cells or other kinds of symptoms.
There has been an increase in the insistence for the development of an inexpensive and easy-to-handle biochip for clinical diagnostics by using plastic microfluidic chips that are fully integrated and which have the identifying or sampling capability of reliable and fast metabolic parameter measurements from a patient and that too with no or minimal invasion. Therefore, the augmentation of clinical diagnostics is predicted to aid the expansion of the global microfluidics market size.
The North America region accounts the largest microfluidics market share and it is predicted to continue its domination over the forecast period. This is credited to factors, for instance, the better reimbursement policies coupled with a well-established healthcare system and the higher adoption rate of advanced therapies amongst the population. Microfluidics is growing at a meteoric pace, especially in the U.S, with respect to massive budget sanctions for research and development. Point-of-care and molecular diagnostics primarily use microfluidic techniques for multiple applications, and thus, they account a large market share in the U.S. Due to this, the U.S holds most of the market share in the North American region.
Major market players are Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson and Co., Illumina, F. Hoffmann-La Roche, Fluidigm Corp., Dolomite Microfludics, Qiagen, Abbott Laboratories, Biomerieux, Microfludic Chipshop, Elveflow, Celix, Micronit Microtechnologies.
Microfluidics Market Segmentation:
By Application
By Component
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Microfluidics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Microfluidics Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Microfluidics Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Microfluidics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Microfluidics Market , By Application Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. In-Vitro Diagnostics 7.1.1. Point-of-Care Testing 7.1.2. Clinical Diagnostics 7.2. Pharmaceutical and Life Science Research 7.2.1. Lab Analytics 7.2.1.1. Proteomic Analysis 7.2.1.2. Genomic Analysis 7.2.1.3. Cell-Based Assays 7.2.1.4. Capillary Electrophoresis 7.2.2. Microdispensing 7.2.3. Microreaction 7.3. Drug Delivery 7.4 Laboratory Testing 7.4.1. Agro Food Testing 7.4.2. Industrial Testing 7.4.3. Environmental Testing 8. Global Microfluidics Market , By Component Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. By Type 8.1.1. Microfluidic Chips 8.1.2. Microfluidic Sensors 8.1.3. Micropumps 8.1.4. Microneedles 8.1.5. Other Components 8.2. By Material 8.2.1. Polymer 8.2.2. Glass 8.2.3. Silicon 8.2.4. Other Materials 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Danaher 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Thermo Fisher Scientific 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Perkinelmer 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Agilent Technologies 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Bio-Rad Laboratories 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Becton 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Dickinson and Co. 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Illumina 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. F. Hoffmann-La Roche. 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Fluidigm Corp. 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Dolomite Microfludics. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Qiagen. 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Abbott Laboratories. 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. Biomerieux. 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15. Microfludic Chipshop 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 14.16. Elveflow 14.16.1. Company Overview 14.16.2. Product Portfolio 14.16.3. SWOT Analysis 14.16.4. Financial Overview 14.16.5. Strategic Overview 14.17. Celix 14.17.1. Company Overview 14.17.2. Product Portfolio 14.17.3. SWOT Analysis 14.17.4. Financial Overview 14.17.5. Strategic Overview 14.18. Micronit Microtechnologies 14.18.1. Company Overview 14.18.2. Product Portfolio 14.18.3. SWOT Analysis 14.18.4. Financial Overview 14.18.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics